# Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

> **NCT00376103** · PHASE1,PHASE2 · TERMINATED · sponsor: **Methodist Healthcare** · enrollment: 3 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** temozolomide
- **PROCEDURE:** Brachytherapy
- **PROCEDURE:** External Beam Radiation Therapy

## Key facts

- **NCT ID:** NCT00376103
- **Lead sponsor:** Methodist Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Loss of funding from sponsor
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376103, "Radiation Boost for Newly Diagnosed Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00376103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*